They are not measurements of every person who uses or has stopped GLP-1 medication in everyday life
Biochemical and cellular properties of insulin receptor signalling
Neeraj Sharma, CEO and Managing Director, OneSource Specialty Pharma, outlines, The global market for GLP1based therapies is experiencing unprecedented growth, given the increasing incidence of Type 2 diabetes and obesity and its efficacy in the management of both diseases
doi: 10.1182/blood-2005-09-3808 92 VermaV
It enhances cellular metabolism and antioxidant defences, promotes wound healing and supports immune function
Its biological activity spans tissue repair, cytoprotection, and modulation of nitric oxide signaling